Investigators trialed injection of an immune-stimulating substance (poly-ICLC) into the prostate gland using MRI-ultrasound fusion technology in patients scheduled to undergo radical prostatectomy.
News-Medical.Net on MSN
Oxybutynin shows promise in managing hot flashes for prostate cancer patients
A national clinical trial led by the Alliance for Clinical Trials in Oncology has found that oxybutynin, a drug often used to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results